Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common shares, no par value
-
Shares outstanding
-
18.8M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
2.12M
-
Shares change
-
-87.6K
-
Total reported value, excl. options
-
$4.9M
-
Value change
-
-$367K
-
Number of buys
-
9
-
Number of sells
-
-13
-
Price
-
$2.32
Significant Holders of Medicus Pharma Ltd. - Common shares, no par value (MDCX) as of Q3 2025
27 filings reported holding MDCX - Medicus Pharma Ltd. - Common shares, no par value as of Q3 2025.
Medicus Pharma Ltd. - Common shares, no par value (MDCX) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.12M shares
of 18.8M outstanding shares and own 11.3% of the company stock.
Largest 10 shareholders include Interchange Capital Partners, LLC (1.59M shares), Yorkville Advisors Global, LP (230K shares), Private Advisor Group, LLC (152K shares), Wilmington Savings Fund Society, FSB (25.6K shares), BRAVE ASSET MANAGEMENT INC (20K shares), LPL Financial LLC (18.8K shares), May Hill Capital, LLC (17.8K shares), BlackRock, Inc. (16.2K shares), OSAIC HOLDINGS, INC. (14K shares), and Base Wealth Management LLC (11.5K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.